During the past decade, CPClin-Centro de Pesquisas Clinicas conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 19 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 14 clinical trials were completed. i.e. 82.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CPClin-Centro de Pesquisas Clinicas" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Mannkind Corporation" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CPClin-Centro de Pesquisas Clinicas" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CPClin-Centro de Pesquisas Clinicas" are "Type 2 Diabetes" (6 trials), "Obesity" (5 trials), "Diabetes Mellitus, Type 2" (4 trials), "Overweight" (4 trials) and "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "CPClin-Centro de Pesquisas Clinicas" in a lesser frequency.

Most popular intervention types in "CPClin-Centro de Pesquisas Clinicas" are "Drug" (38 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Tirzepatide" (9 trials), "Technosphere Insulin" (4 trials), "Empagliflozin" (3 trials) and "Dulaglutide" (2 trials). Other intervention names were less common.

The vast majority of trials in "CPClin-Centro de Pesquisas Clinicas" are 38 trials for "All" genders.

Currently, there are NaN active trials in "CPClin-Centro de Pesquisas Clinicas". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in CPClin-Centro de Pesquisas Clinicas, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CPClin-Centro de Pesquisas Clinicas, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".